13F filing recap · Q4 2025
What did Trian Fund Management buy in Q4 2025?
Reported stock-position changes between this filing and the previous one.
Stock value
$3.98B
Positions
7
Estimated turnover
8.0%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Trian Fund Management slightly increased its General Electric and Wendy's positions while modestly trimming Solventum. The firm substantially reduced its Invesco stake and slightly added to GE Healthcare Technologies.